Clinical trial
Anticonvulsant Mood Stabilizers, Antipsychotic Drugs and the Insulin Resistance…
NCT00288366 · Northwestern University, Other · Completed
Key facts
| NCT number | NCT00288366 |
|---|---|
| Title | Anticonvulsant Mood Stabilizers, Antipsychotic Drugs and the Insulin Resistance Syndrome |
| Official title | Anticonvulsant Mood Stabilizers, Antipsychotic Drugs and the Insulin Resistance Syndrome |
| Lead sponsor | Northwestern University, Other |
| Collaborators | National Alliance for Research on Schizophrenia and Depression Pfizer Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Schizophrenia, Schizoaffective Disorder, Bipolar Disorder |
| Intervention type | Drug |
| Interventions | ziprasidone vs. aripiprazole, aripiprazole vs. ziprasidone |
| Enrollment | 49 |
| Start date | Jan 1, 2006 |
| Primary completion | Dec 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Feb 7, 2006 |
| Last update posted | Aug 6, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: